Kaletra (lopinavir/ritonavir) oral solution, 2 bottle pack containing 2-ml oral dosing syringes: Presence of amide particles in 2-ml oral dosing syringes
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
Medicine name |
Kaletra
|
Active substance |
|
Therapeutic area (MeSH) |
HIV Infections
|
Procedure number |
EMEA/H/C/000368
|
DHPC type |
Quality defect
|
Dissemination date |
23/12/2020
|